Last updated: June 13, 2026

Bunkerhill Carebricks medical AI product profile

Opportunistic CT AI and care-coordination platform that combines FDA-cleared imaging algorithms with workflow automation for follow-up on actionable findings.

Medical imaging and radiology

Best fit

Health systems that want to convert routine CT findings into supervised preventive-care, referral, counseling, DEXA, echocardiography, cardiology, or surveillance workflows.

Primary use case: Generative workflow platform and FDA-cleared CT algorithms that surface actionable incidental findings such as coronary artery calcium, aortic valve calcification, abdominal aortic enlargement, mitral annular calcification, and low bone density for clinician review and care coordination
Audience: Radiology departments, population-health teams, cardiology programs, bone-health programs, clinical operations leaders, and health systems evaluating opportunistic CT finding workflows
Risk level: High
Pricing signal: Enterprise pricing is not published; request current algorithm, Carebricks workflow, EHR/PACS integration, outreach, support, privacy, and deployment terms.
Official sources: 7 official sources

Compare within workflow: Medical imaging and radiology · comparison shortlist · source index

Regulatory snapshot

Status	Multiple FDA-cleared CT-analysis algorithms are described in public materials; status and scope vary by Bunkerhill feature.
Review route	510(k), including records such as K230223 for iCAC, K242295 for BMD, K243229 for AVC, K243779 for AAQ, K250662 for MAC, and K260167 for Contrast AVC.
Intended use	Analyzes specified routine CT studies for defined calcification, bone-density, or aortic measurements and makes outputs available to physicians for review; outputs should not be used as standalone diagnosis or treatment decisions.
Verification note	Procurement should map every Carebricks workflow to a specific cleared algorithm, version, CT protocol, patient age range, output, clinician-review step, and follow-up policy.
Source	www.accessdata.fda.gov / scripts / cdrh

Regulatory, privacy, evidence, and workflow lens

Product-specific review. These product-specific signals summarize what the cited sources imply before treating Bunkerhill Carebricks as safe for a local clinical, operational, or research workflow.

Regulatory / FDA	Treat each Bunkerhill algorithm as a separate high-risk imaging SaMD workflow. Match the deployed feature, anatomy, CT acquisition type, age range, output, 510(k), and physician-review language before connecting it to outreach or care-coordination automation.
Privacy	Review DICOM routing, EHR integration, edge versus cloud processing, re-identification, patient outreach data, scheduling messages, support access, retention, audit logs, BAA terms, security certifications, and whether public privacy language differs from contracted clinical data terms.
Evidence	Use FDA summaries, vendor validation materials, and local retrospective pilots to assess algorithm performance, incidental finding burden, false-positive and false-negative risk, follow-up completion, equity, and whether downstream interventions improve care rather than only increasing work.
Workflow	Best governed by radiology, cardiology, primary care, bone health, vascular, imaging IT, privacy, and patient-access teams defining review queues, signoff requirements, patient communication, referral ownership, downtime procedures, and post-launch monitoring.

Where Bunkerhill Carebricks fits

Bunkerhill describes Carebricks workflows that use FDA-cleared algorithms to detect elevated CAC, low bone density, aortic valve calcification, abdominal aortic enlargement, and other findings on routine CT studies, then coordinate review, outreach, and follow-up. Its BMD clearance page says Bunkerhill BMD analyzes spinal bone structures from non-contrast abdominal CT in adults 30 and older and can support detection-to-follow-up workflows through Carebricks. FDA records list Bunkerhill AAQ as automated radiological image processing software, K242295 for BMD, K260167 for Contrast AVC, and K250662 for MAC, with physician-review and non-standalone-use language buyers should preserve in deployment policy. Public security and privacy materials reference HIPAA, SOC 2 Type II, ISO 27001, and personal-information handling that must be verified contractually for clinical data use.

Not for: Standalone diagnosis, replacing radiologist or physician review, automated outreach without local policy approval, or use where CT indication, device version, consent, PHI flow, and follow-up ownership are undefined.

What to verify before using Bunkerhill Carebricks

Which Bunkerhill algorithm is in scope, such as iCAC, BMD, AVC, Contrast AVC, AAQ, MAC, or another Carebricks workflow, and which FDA 510(k) and intended-use statement applies.
Whether the CT acquisition type, contrast status, body region, age range, scanner protocol, slice thickness, and local patient population match the cleared algorithm and validation assumptions.
How DICOM images, reports, EHR data, outreach tasks, patient messages, scheduling data, algorithm outputs, clinician signoff, retention, and audit logs flow between PACS, EHR, Bunkerhill Edge or cloud processing, and Carebricks.
Who reviews incidental finding outputs before they affect patient outreach, diagnosis labels, medication discussions, DEXA orders, echo recommendations, referrals, or surveillance intervals.
Local validation plan for false positives, missed findings, radiologist workload, follow-up completion, preventive-care uptake, equity, patient anxiety, downstream imaging, and clinical outcomes.

Source links

Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.

Bunkerhill Carebricks medical AI product profile

Best fit

Regulatory snapshot

Regulatory, privacy, evidence, and workflow lens

Where Bunkerhill Carebricks fits

What to verify before using Bunkerhill Carebricks

Source links

Related medical AI products

Riverain ClearRead CT

Aidoc

AIRS Medical SwiftMR

Viz.ai